These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27690729)

  • 1. Endothelin-1 receptor drives invadopodia: Exploiting how β-arrestin-1 guides the way.
    Bagnato A; Rosanò L
    Small GTPases; 2018 Sep; 9(5):394-398. PubMed ID: 27690729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
    Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
    Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK.
    Masi I; Caprara V; Spadaro F; Chellini L; Sestito R; Zancla A; Rainer A; Bagnato A; Rosanò L
    Cell Rep; 2021 Mar; 34(9):108800. PubMed ID: 33657382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
    Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
    Rosanò L; Bagnato A
    J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The β-arrestin1/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential.
    Del Rio D; Masi I; Caprara V; Ottavi F; Albertini Petroni G; Salvati E; Trisciuoglio D; Giannitelli SM; Bagnato A; Mauri E; Spadaro F; Rosanò L
    Cell Death Dis; 2024 May; 15(5):358. PubMed ID: 38777849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.
    Masi I; Ottavi F; Del Rio D; Caprara V; Vastarelli C; Giannitelli SM; Fianco G; Mozetic P; Buttarelli M; Ferrandina G; Scambia G; Gallo D; Rainer A; Bagnato A; Spadaro F; Rosanò L
    Cell Death Dis; 2023 Jan; 14(1):73. PubMed ID: 36717550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.
    Rosanò L; Cianfrocca R; Sestito R; Tocci P; Di Castro V; Bagnato A
    Expert Opin Ther Targets; 2017 Oct; 21(10):925-932. PubMed ID: 28758529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods to Investigate β-Arrestin-1/β-Catenin Signaling in Ovarian Cancer Cells.
    Rosanò L; Cianfrocca R; Bagnato A
    Methods Mol Biol; 2019; 1957():393-406. PubMed ID: 30919368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
    Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
    Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KISS1R signaling promotes invadopodia formation in human breast cancer cell via β-arrestin2/ERK.
    Goertzen CG; Dragan M; Turley E; Babwah AV; Bhattacharya M
    Cell Signal; 2016 Mar; 28(3):165-176. PubMed ID: 26721186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
    Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia.
    Bravo-Cordero JJ; Oser M; Chen X; Eddy R; Hodgson L; Condeelis J
    Curr Biol; 2011 Apr; 21(8):635-44. PubMed ID: 21474314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer.
    Tocci P; Caprara V; Cianfrocca R; Sestito R; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2016 Aug; 159():49-54. PubMed ID: 26776837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells.
    Goicoechea SM; Zinn A; Awadia SS; Snyder K; Garcia-Mata R
    J Cell Sci; 2017 Mar; 130(6):1064-1077. PubMed ID: 28202690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
    Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
    Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role for PAK1 and PAK4 during the invadopodia lifecycle.
    Nicholas NS; Pipili A; Lesjak MS; Wells CM
    Small GTPases; 2019 Jul; 10(4):289-295. PubMed ID: 28301299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.
    Peláez R; Morales X; Salvo E; Garasa S; Ortiz de Solórzano C; Martínez A; Larrayoz IM; Rouzaut A
    PLoS One; 2017; 12(8):e0181579. PubMed ID: 28767724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
    Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
    Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.